Glenmark expands specialty portfolio with OTIPRIO co-promotion agreement in the U.S.
MUMBAI, INDIA: Glenmark Therapeutics Inc., USA, a wholly-owned subsidiary of Glenmark Holding SA., has announced a co-promotion agreement with Otonomy Inc., a biopharmaceutical company dedicated to the development of innovative…